CoChat

IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo

Bralten, Linda B. C., Kloosterhof, Nanne K., Balvers, Rutger, Sacchetti, Andrea, Lapre, Lariesa, Lamfers, Martine, Leenstra, Sieger, de Jonge, Hugo, Kros, Johan M., Jansen, Erwin E. W., Struys, Eduard A., Jakobs, Cornelis, Salomons, Gajja S., Diks, Sander H., Peppelenbosch, Maikel, Kremer, Andreas, Hoogenraad, Casper C., Sillevis Smitt, Peter A. E., French, Pim J. · 2011 · Annals of Neurology
Cited by 141

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitrate dehydrogenase (IDH1). This mutation is always a heterozygous point mutation that affects the amino acid arginine at position 132 and results in loss of its native enzymatic activity and gain of alternative enzymatic activity (producing D‐2‐hydroxyglutarate). The objective of this study was to investigate the cellular effects of R132H mutations in IDH1. Methods: Functional consequences of IDH1 R132H mutations were examined among others using fluorescence‐activated cell sorting, kinome and expression arrays, biochemical assays, and intracranial injections on 3 different (glioma) cell lines with stable overexpression of IDH1 R132H. Results: IDH1 R132H overexpression in established glioma cell lines in vitro resulted in a marked decrease in proliferation, decreased Akt phosphorylation, altered morphology, and a more contact‐dependent cell migration. The reduced proliferation is related to accumulation of D‐2‐hydroxyglutarate that is produced by IDH1 R132H. Mice injected with IDH1 R132H U87 cells have prolonged survival compared to mice injected with IDH1 wt or green fluorescent protein–expressing U87 cells. Interpretation: Our results demonstrate that IDH1 R132H dominantly reduces aggressiveness of established glioma cell lines in vitro and in vivo. In addition, the IDH1 R132H‐IDH1 wt heterodimer has higher enzymatic activity than the IDH1 R132H‐IDH1 R132H homodimer. Our observations in model systems of glioma might lead to a better understanding of the biology of IDH1 mutant gliomas, which are typically low grade and often slow growing. Ann Neurol 2011;69:455–463

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.22390

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 141

Metadata

Authors
Bralten, L. B. C., Kloosterhof, N. K., Balvers, R., Sacchetti, A., Lapre, L., Lamfers, M., Leenstra, S., de Jonge, H., Kros, J. M., Jansen, E. E. W., Struys, E. A., Jakobs, C., Salomons, G. S., Diks, S. H., Peppelenbosch, M., Kremer, A., Hoogenraad, C. C., Sillevis Smitt, P. A. E., & French, P. J.
Venue
Annals of Neurology
Publisher
Wiley
Published
2011-03
Volume
69
Issue
3
Pages
455-463
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2149363397
Cited by
141
References
13
FWCI
6.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo. https://app.cochat.ai/papers/10.1002/ana.22390
The paper
Bralten, L. B. C., Kloosterhof, N. K., Balvers, R., Sacchetti, A., Lapre, L., Lamfers, M., Leenstra, S., de Jonge, H., Kros, J. M., Jansen, E. E. W., Struys, E. A., Jakobs, C., Salomons, G. S., Diks, S. H., Peppelenbosch, M., Kremer, A., Hoogenraad, C. C., Sillevis Smitt, P. A. E., & French, P. J. (2011). IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo. Annals of Neurology. https://doi.org/10.1002/ana.22390

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.